Constellation Energy Corporation vs ClearPoint Neuro Inc — how do they compare? Constellation Energy Corporation trades at $279.65 (market cap $98.63B), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: Constellation Energy Corporation is far larger — about 217.1× ClearPoint Neuro Inc's market cap, and Constellation Energy Corporation pays a 0.61% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CEG | CLPT | |
|---|---|---|
Market Cap | $98.63B | $454.21M |
Sector | Energy | Health |
52-Week High | $403.95 | $29.60 |
52-Week Low | $236.50 | $8.66 |
Enterprise Value | $122.63B | $488.79M |
Dividend Yield | 0.61% | — |
Signals from Pluang's Aura AI — not financial advice
Constellation Energy (CEG) trades at $269.89, up 3.37% with a bullish technical outlook. The stock shows strong fundamentals with Q2 2026 EPS beating estimates at $2.55 versus $2.29 expected, and the company raised its 2026 guidance. Recent news highlights new power deals, including a Walmart PPA, and the acquisition of Calpine, positioning CEG to benefit from AI-driven electricity demand.
The outlook is positive with a consensus price target of $333.14, implying significant upside. Key opportunities include nuclear energy's role in the AI power boom and strong cash flow generation. Risks involve execution of growth initiatives and potential regulatory changes affecting the utilities sector.
ClearPoint Neuro (CLPT) trades at $14.21, up 6.12% today, amid mixed technical signals and challenging fundamentals. The company reported Q2 2026 revenue growth but missed earnings expectations with a loss of $0.38 per share, continuing a trend of negative profitability. Despite 100% analyst buy ratings, financial metrics show significant losses with a net income margin of -81.76% and negative cash flow from operations of $30 million projected for 2026.
The investment case hinges on regulatory progress and partnership developments in neurotechnology, but substantial execution risks and persistent losses present headwinds. While analyst consensus remains bullish on long-term potential, current financial performance suggests cautious optimism is warranted until profitability improves.
Trailing returns across standard periods
Latest headlines on both assets
Constellation is the largest producer of carbon-free energy in the U.S. and a leading nuclear power plant operator. It provides sustainable electricity to millions of residential, public, and industrial customers.
Read more on CEG →ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →